Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 44 | 2024 | 1046 | 11.270 |
Why?
|
Image Interpretation, Computer-Assisted | 52 | 2024 | 3340 | 7.760 |
Why?
|
Myocardium | 44 | 2024 | 4700 | 6.910 |
Why?
|
Heart | 42 | 2024 | 4393 | 6.320 |
Why?
|
Gadolinium | 21 | 2024 | 959 | 5.560 |
Why?
|
Magnetic Resonance Imaging | 84 | 2024 | 36290 | 4.850 |
Why?
|
Image Enhancement | 40 | 2021 | 2881 | 4.770 |
Why?
|
Cardiomyopathy, Hypertrophic | 12 | 2023 | 1311 | 3.840 |
Why?
|
Respiratory-Gated Imaging Techniques | 11 | 2022 | 75 | 3.760 |
Why?
|
Cicatrix | 19 | 2023 | 782 | 3.610 |
Why?
|
Imaging, Three-Dimensional | 35 | 2020 | 4048 | 3.560 |
Why?
|
Magnetic Resonance Angiography | 18 | 2014 | 1431 | 3.460 |
Why?
|
Cardiac-Gated Imaging Techniques | 11 | 2015 | 140 | 3.230 |
Why?
|
Artifacts | 20 | 2021 | 1898 | 3.170 |
Why?
|
Contrast Media | 31 | 2024 | 5305 | 3.110 |
Why?
|
Meglumine | 8 | 2019 | 145 | 2.580 |
Why?
|
Organometallic Compounds | 9 | 2019 | 662 | 2.500 |
Why?
|
Ventricular Function, Left | 19 | 2024 | 3880 | 2.390 |
Why?
|
Coronary Vessels | 18 | 2015 | 3112 | 2.360 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2024 | 819 | 2.280 |
Why?
|
Cardiac Imaging Techniques | 5 | 2018 | 269 | 2.230 |
Why?
|
Heart Ventricles | 14 | 2023 | 3811 | 2.220 |
Why?
|
Phantoms, Imaging | 25 | 2023 | 2512 | 2.120 |
Why?
|
Signal Processing, Computer-Assisted | 9 | 2018 | 1489 | 1.880 |
Why?
|
Blood Flow Velocity | 7 | 2021 | 1377 | 1.870 |
Why?
|
Reproducibility of Results | 54 | 2023 | 20080 | 1.840 |
Why?
|
Predictive Value of Tests | 37 | 2024 | 15289 | 1.780 |
Why?
|
Tachycardia, Ventricular | 9 | 2020 | 1303 | 1.730 |
Why?
|
Pulmonary Veins | 7 | 2015 | 745 | 1.680 |
Why?
|
Algorithms | 36 | 2018 | 13981 | 1.660 |
Why?
|
Respiratory Mechanics | 8 | 2015 | 699 | 1.570 |
Why?
|
Stroke Volume | 12 | 2024 | 5523 | 1.560 |
Why?
|
Image Processing, Computer-Assisted | 19 | 2020 | 8950 | 1.450 |
Why?
|
Respiration | 9 | 2021 | 1654 | 1.430 |
Why?
|
Cardiomyopathies | 8 | 2024 | 1952 | 1.390 |
Why?
|
Defibrillators, Implantable | 7 | 2024 | 1499 | 1.380 |
Why?
|
Heart Atria | 6 | 2018 | 1346 | 1.340 |
Why?
|
Data Compression | 3 | 2014 | 69 | 1.260 |
Why?
|
Myocardial Infarction | 13 | 2019 | 11891 | 1.160 |
Why?
|
Heart Diseases | 6 | 2019 | 2809 | 1.130 |
Why?
|
Heart Rate | 9 | 2022 | 4179 | 1.130 |
Why?
|
Fibrosis | 13 | 2024 | 2042 | 1.110 |
Why?
|
Catheter Ablation | 10 | 2020 | 2758 | 0.980 |
Why?
|
Doxorubicin | 2 | 2024 | 2209 | 0.980 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2024 | 2128 | 0.960 |
Why?
|
Sensitivity and Specificity | 31 | 2020 | 14660 | 0.960 |
Why?
|
Papillary Muscles | 3 | 2016 | 192 | 0.940 |
Why?
|
Arrhythmias, Cardiac | 6 | 2024 | 2255 | 0.930 |
Why?
|
Atrial Fibrillation | 10 | 2018 | 5209 | 0.930 |
Why?
|
Ventricular Remodeling | 7 | 2020 | 1261 | 0.920 |
Why?
|
Coronary Circulation | 6 | 2019 | 1577 | 0.840 |
Why?
|
Endomyocardial Fibrosis | 2 | 2020 | 41 | 0.830 |
Why?
|
Models, Cardiovascular | 4 | 2019 | 978 | 0.830 |
Why?
|
Gadolinium DTPA | 6 | 2013 | 823 | 0.820 |
Why?
|
Male | 97 | 2024 | 359744 | 0.810 |
Why?
|
Swine, Miniature | 2 | 2024 | 959 | 0.800 |
Why?
|
Motion | 11 | 2018 | 779 | 0.800 |
Why?
|
Heart Conduction System | 2 | 2019 | 1015 | 0.790 |
Why?
|
Exercise Test | 3 | 2022 | 2128 | 0.770 |
Why?
|
Humans | 140 | 2024 | 760621 | 0.770 |
Why?
|
Middle Aged | 66 | 2024 | 220352 | 0.760 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2021 | 571 | 0.730 |
Why?
|
Female | 90 | 2024 | 391270 | 0.720 |
Why?
|
Atrial Function, Left | 2 | 2018 | 186 | 0.710 |
Why?
|
Adult | 65 | 2024 | 219994 | 0.700 |
Why?
|
Myocardial Contraction | 4 | 2020 | 1516 | 0.690 |
Why?
|
Magnetic Resonance Spectroscopy | 8 | 2024 | 3765 | 0.690 |
Why?
|
Electrocardiography | 11 | 2022 | 6414 | 0.640 |
Why?
|
Swine | 14 | 2024 | 5899 | 0.620 |
Why?
|
Electrophysiologic Techniques, Cardiac | 6 | 2020 | 504 | 0.620 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2019 | 152 | 0.610 |
Why?
|
Holography | 1 | 2018 | 79 | 0.600 |
Why?
|
Coronary Artery Disease | 6 | 2022 | 6659 | 0.600 |
Why?
|
Movement | 5 | 2018 | 1474 | 0.590 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1921 | 0.580 |
Why?
|
Body Surface Potential Mapping | 3 | 2017 | 228 | 0.560 |
Why?
|
Prospective Studies | 21 | 2024 | 54303 | 0.550 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 994 | 0.540 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1726 | 0.540 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 615 | 0.530 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2015 | 30 | 0.530 |
Why?
|
Aorta | 4 | 2014 | 2039 | 0.500 |
Why?
|
Mitral Valve Prolapse | 3 | 2016 | 215 | 0.500 |
Why?
|
Angina Pectoris | 1 | 2019 | 969 | 0.500 |
Why?
|
Aged | 37 | 2024 | 169152 | 0.500 |
Why?
|
Veins | 2 | 2010 | 765 | 0.490 |
Why?
|
Subtraction Technique | 2 | 2015 | 510 | 0.480 |
Why?
|
Sarcoidosis | 1 | 2020 | 520 | 0.480 |
Why?
|
Blood | 1 | 2017 | 586 | 0.480 |
Why?
|
Sus scrofa | 4 | 2019 | 433 | 0.470 |
Why?
|
Retrospective Studies | 23 | 2024 | 80372 | 0.460 |
Why?
|
Myocardial Stunning | 1 | 2014 | 66 | 0.460 |
Why?
|
Acceleration | 1 | 2014 | 189 | 0.450 |
Why?
|
Radio Waves | 2 | 2012 | 250 | 0.450 |
Why?
|
Coronary Angiography | 7 | 2019 | 4563 | 0.450 |
Why?
|
Hyperventilation | 1 | 2013 | 79 | 0.450 |
Why?
|
Feasibility Studies | 7 | 2022 | 5201 | 0.440 |
Why?
|
Primary Prevention | 3 | 2024 | 1207 | 0.440 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18137 | 0.440 |
Why?
|
Phlebography | 1 | 2014 | 325 | 0.440 |
Why?
|
Adipose Tissue | 2 | 2018 | 3301 | 0.440 |
Why?
|
Respiratory Rate | 1 | 2014 | 175 | 0.440 |
Why?
|
Pericardium | 1 | 2018 | 675 | 0.440 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2019 | 854 | 0.440 |
Why?
|
Magnetics | 2 | 2018 | 600 | 0.430 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2557 | 0.420 |
Why?
|
Computer Simulation | 8 | 2018 | 6218 | 0.420 |
Why?
|
Myocarditis | 1 | 2020 | 766 | 0.410 |
Why?
|
Death, Sudden, Cardiac | 4 | 2023 | 1572 | 0.410 |
Why?
|
Electrodiagnosis | 1 | 2012 | 148 | 0.400 |
Why?
|
Action Potentials | 1 | 2019 | 1816 | 0.390 |
Why?
|
Wavelet Analysis | 1 | 2011 | 55 | 0.380 |
Why?
|
Echo-Planar Imaging | 1 | 2014 | 657 | 0.350 |
Why?
|
Stilbenes | 4 | 2012 | 155 | 0.350 |
Why?
|
Isosorbide Dinitrate | 1 | 2010 | 37 | 0.350 |
Why?
|
Mitral Valve | 2 | 2016 | 1486 | 0.340 |
Why?
|
Electric Countershock | 1 | 2013 | 537 | 0.340 |
Why?
|
Reference Values | 5 | 2016 | 4925 | 0.340 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15757 | 0.330 |
Why?
|
Heart Failure | 3 | 2021 | 11847 | 0.320 |
Why?
|
Hypertension | 2 | 2019 | 8594 | 0.320 |
Why?
|
Myocardial Ischemia | 5 | 2013 | 2164 | 0.320 |
Why?
|
Amyloidosis | 1 | 2015 | 817 | 0.310 |
Why?
|
Young Adult | 16 | 2019 | 58741 | 0.300 |
Why?
|
Time Factors | 10 | 2024 | 40165 | 0.290 |
Why?
|
Numerical Analysis, Computer-Assisted | 2 | 2020 | 119 | 0.290 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1097 | 0.280 |
Why?
|
Mitral Valve Insufficiency | 1 | 2016 | 1419 | 0.280 |
Why?
|
Supine Position | 2 | 2019 | 205 | 0.270 |
Why?
|
Automation | 2 | 2019 | 580 | 0.260 |
Why?
|
Water | 1 | 2012 | 1407 | 0.260 |
Why?
|
Brain Chemistry | 1 | 2009 | 959 | 0.250 |
Why?
|
Vasodilator Agents | 1 | 2010 | 978 | 0.250 |
Why?
|
Case-Control Studies | 7 | 2019 | 22053 | 0.250 |
Why?
|
Normal Distribution | 2 | 2018 | 273 | 0.240 |
Why?
|
Models, Theoretical | 4 | 2018 | 3562 | 0.240 |
Why?
|
Observer Variation | 4 | 2020 | 2601 | 0.230 |
Why?
|
Pilot Projects | 6 | 2019 | 8555 | 0.220 |
Why?
|
Radiography | 3 | 2024 | 6965 | 0.210 |
Why?
|
Oxygen | 1 | 2013 | 4193 | 0.200 |
Why?
|
Polyethylene | 1 | 2023 | 186 | 0.200 |
Why?
|
Echocardiography | 2 | 2021 | 4981 | 0.200 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.190 |
Why?
|
Animals | 18 | 2024 | 167963 | 0.190 |
Why?
|
Principal Component Analysis | 1 | 2024 | 940 | 0.190 |
Why?
|
Adaptation, Biological | 1 | 2001 | 147 | 0.180 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2852 | 0.180 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 848 | 0.180 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 675 | 0.170 |
Why?
|
Risk Factors | 8 | 2023 | 74359 | 0.160 |
Why?
|
Infarction | 1 | 2020 | 248 | 0.160 |
Why?
|
Epicardial Mapping | 1 | 2018 | 56 | 0.160 |
Why?
|
Prognosis | 4 | 2024 | 29658 | 0.160 |
Why?
|
Hand Strength | 1 | 2001 | 452 | 0.160 |
Why?
|
Arm | 1 | 2001 | 583 | 0.150 |
Why?
|
Motor Skills | 1 | 2001 | 520 | 0.150 |
Why?
|
Tissue Survival | 1 | 2018 | 119 | 0.150 |
Why?
|
Endocardium | 2 | 2017 | 246 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 12922 | 0.150 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 309 | 0.140 |
Why?
|
Electrodes | 2 | 2017 | 614 | 0.140 |
Why?
|
Echocardiography, Doppler | 2 | 2019 | 901 | 0.140 |
Why?
|
Exercise | 1 | 2013 | 5787 | 0.140 |
Why?
|
Risk Assessment | 6 | 2024 | 24123 | 0.140 |
Why?
|
Patient Positioning | 1 | 2019 | 327 | 0.140 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2019 | 479 | 0.130 |
Why?
|
Microelectrodes | 1 | 2017 | 304 | 0.130 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58995 | 0.130 |
Why?
|
Collagen | 1 | 2024 | 2636 | 0.130 |
Why?
|
Recurrence | 3 | 2018 | 8482 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 682 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39261 | 0.120 |
Why?
|
Catheters | 2 | 2020 | 425 | 0.120 |
Why?
|
Time | 1 | 2017 | 545 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 584 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2019 | 65017 | 0.120 |
Why?
|
Ventricular Fibrillation | 1 | 2017 | 539 | 0.120 |
Why?
|
Equipment Design | 2 | 2014 | 3520 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 707 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1067 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1180 | 0.120 |
Why?
|
Cerebellum | 1 | 2001 | 1496 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 852 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.110 |
Why?
|
Linear Models | 2 | 2016 | 5877 | 0.110 |
Why?
|
Biopsy | 1 | 2024 | 6771 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2009 | 20509 | 0.100 |
Why?
|
Diaphragm | 1 | 2013 | 351 | 0.100 |
Why?
|
Organ Size | 1 | 2016 | 2254 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 2733 | 0.090 |
Why?
|
Ventricular Function | 1 | 2012 | 408 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15840 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2014 | 1578 | 0.090 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 369 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3465 | 0.090 |
Why?
|
Administration, Sublingual | 1 | 2010 | 58 | 0.090 |
Why?
|
Systole | 1 | 2012 | 947 | 0.090 |
Why?
|
Cardiac Output | 1 | 2012 | 838 | 0.090 |
Why?
|
Diastole | 1 | 2012 | 788 | 0.090 |
Why?
|
Boston | 2 | 2020 | 9280 | 0.090 |
Why?
|
Aortic Valve | 1 | 2019 | 1996 | 0.080 |
Why?
|
Endoscopy | 1 | 2018 | 1838 | 0.080 |
Why?
|
Adolescent | 4 | 2019 | 87810 | 0.080 |
Why?
|
Adiposity | 1 | 2018 | 1858 | 0.080 |
Why?
|
Coronary Stenosis | 1 | 2014 | 820 | 0.070 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1206 | 0.070 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2006 | 110 | 0.070 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 1336 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3959 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2012 | 1403 | 0.070 |
Why?
|
Prosthesis Design | 1 | 2013 | 2135 | 0.070 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2234 | 0.060 |
Why?
|
Microcirculation | 1 | 2010 | 1278 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6544 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1667 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 470 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1155 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12965 | 0.050 |
Why?
|
Calibration | 1 | 2005 | 816 | 0.050 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12159 | 0.050 |
Why?
|
Sepharose | 1 | 2023 | 105 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2011 | 2326 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14495 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6828 | 0.050 |
Why?
|
Brain | 1 | 2009 | 26951 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2001 | 51 | 0.050 |
Why?
|
Child | 2 | 2020 | 79806 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12531 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4283 | 0.050 |
Why?
|
Cerebellar Cortex | 1 | 2001 | 107 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2005 | 822 | 0.040 |
Why?
|
Pliability | 1 | 2019 | 58 | 0.040 |
Why?
|
Models, Statistical | 2 | 2011 | 5075 | 0.040 |
Why?
|
Consensus | 2 | 2020 | 3113 | 0.040 |
Why?
|
Nonlinear Dynamics | 1 | 2001 | 494 | 0.040 |
Why?
|
Software | 1 | 2012 | 4419 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12808 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2001 | 1121 | 0.040 |
Why?
|
Chronic Disease | 3 | 2019 | 9287 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6465 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 41335 | 0.040 |
Why?
|
Coronary Disease | 2 | 2010 | 5990 | 0.030 |
Why?
|
Functional Laterality | 1 | 2001 | 2253 | 0.030 |
Why?
|
Models, Neurological | 1 | 2001 | 1758 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2007 | 3517 | 0.020 |
Why?
|
Glucose Transporter Type 4 | 1 | 2011 | 240 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3441 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Neural Pathways | 1 | 2001 | 3040 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2010 | 223 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 393 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2010 | 292 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2985 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1582 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10756 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2471 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1175 | 0.020 |
Why?
|
Capillaries | 1 | 2010 | 744 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6568 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1376 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 1975 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 898 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3905 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1964 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2222 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5039 | 0.020 |
Why?
|
Treatment Failure | 1 | 2009 | 2648 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9426 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2924 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3106 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8035 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2049 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2634 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4000 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3484 | 0.010 |
Why?
|
Calcinosis | 1 | 2007 | 1476 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3392 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 2272 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6597 | 0.010 |
Why?
|
Stents | 1 | 2007 | 3314 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9467 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11903 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8010 | 0.010 |
Why?
|
Signal Transduction | 1 | 2010 | 23376 | 0.000 |
Why?
|